Daniël van Raalte

DR.

20092019
If you made any changes in Pure these will be visible here soon.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2009 2019

Mineralocorticoid Antagonism and Diabetic Kidney Disease

Lytvyn, Y., Godoy, L. C., Scholtes, R. A., van Raalte, D. H. & Cherney, D. Z., 2019, In : Current Diabetes Reports. 19, 1, 4.

Research output: Contribution to journalReview articleAcademicpeer-review

Renal tubular effects of prolonged therapy with the GLP-1 receptor agonist lixisenatide in patients with type 2 diabetes mellitus

Tonneijck, L., Muskiet, M. H. A., Blijdorp, C. J., Smits, M. M., Twisk, J. W., Kramer, M. H. H., Danser, A. H. J., Diamant, M., Joles, J. A., Hoorn, E. J. & van Raalte, D. H., 2019, In : American Journal of Physiology. Renal Physiology. 316, 2, p. F231-F240

Research output: Contribution to journalArticleAcademicpeer-review

Canagliflozine, een nieuw glucoseverlagend middel

Van Raalte, D. H. & Van Baar, M., 1 Jan 2018, In : Nederlands Tijdschrift voor Geneeskunde. 162, 18, D2755.

Research output: Contribution to journalComment/Letter to the editorAcademic